- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/22 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Neisseriaceae (F), p. ex. Acinetobacter
Détention brevets de la classe C07K 14/22
Brevets de cette classe: 301
Historique des publications depuis 10 ans
|
31
|
17
|
33
|
26
|
23
|
25
|
23
|
16
|
15
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1634 |
55 |
| Pfizer Inc. | 3358 |
33 |
| The Regents of the University of California | 19803 |
18 |
| Aridis Pharmaceuticals Inc. | 26 |
10 |
| Children's Hospital & Research Center at Oakland | 67 |
10 |
| Wyeth LLC | 652 |
7 |
| Wyeth Holdings LLC | 54 |
7 |
| Novartis AG | 10927 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 364 |
5 |
| Oxford University Innovation Limited | 1499 |
5 |
| Engineered Antigens Inc. | 10 |
5 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2138 |
4 |
| MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. | 23 |
4 |
| Sanofi Pasteur Inc. | 354 |
4 |
| T2 Biosystems, Inc. | 120 |
4 |
| University of Massachusetts | 2218 |
4 |
| Cansino Biologics Inc. | 74 |
4 |
| The Board of Trustees of the University of Illinois | 2682 |
3 |
| Asociación Centro de Investigación Cooperativa en Biociencias-cic Biogune | 47 |
3 |
| Centro de Ingenieria Genetica y Biotecnologia | 195 |
3 |
| Autres propriétaires | 107 |